Robert C. Bourge
Impact in
-
- Heart Failure Treatment and Management
- Cardiac pacing and defibrillation studies
- Cardiovascular Function and Risk Factors
- Cardiac Valve Diseases and Treatments
- Pulmonary and Respiratory Medicine top 0.2%
- Pulmonary Hypertension Research and Treatments
Papers in
-
- Heart Failure Treatment and Management 71
- Cardiac pacing and defibrillation studies 6
- Cardiac Valve Diseases and Treatments 4
- Chemotherapy-induced cardiotoxicity and mitigation 3
- Surgery 70
- Transplantation: Methods and Outcomes 67
- Co-authors
- William T. Abraham (46 shared papers)Lynne Warner Stevenson (28 shared papers)Philip B. Adamson (34 shared papers)James K. Kirklin (70 shared papers)Maria Rosa Costanzo (16 shared papers)David C. Naftel (43 shared papers)Robyn J. Barst (8 shared papers)Lewis J. Rubin (6 shared papers)
- Journals
- The Journal of Heart and Lung Transplantation (35 papers)Journal of Cardiac Failure (28 papers)Journal of the American College of Cardiology (22 papers)Circulation (13 papers)American Heart Journal (9 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Robert C. Bourge
248 papers receiving 18.9k citations
Robert C. Bourge's Hit Papers
Peers
Comparison fields: 5 of 104
- Cardiology and Cardiovascular Medicine 6.1k
- Pulmonary and Respiratory Medicine 5.4k
- Surgery 3.3k
- Transplantation 132
- Biomedical Engineering 952
Countries citing papers authored by Robert C. Bourge
This map shows the geographic impact of Robert C. Bourge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert C. Bourge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert C. Bourge more than expected).
Fields of papers citing papers by Robert C. Bourge
This network shows the impact of papers produced by Robert C. Bourge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert C. Bourge. The network helps show where Robert C. Bourge may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert C. Bourge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 252 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension Hit paper breakdown → | 1996 | 2205 |
| 2 | Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial Hit paper breakdown → | 2011 | 1352 |
| 3 | Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled Trial Hit paper breakdown → | 2002 | 1161 |
| 4 | Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease Hit paper breakdown → | 2000 | 876 |
| 5 | 2000 | 738 | |
| 6 | 1998 | 519 | |
| 7 | A RANDOMIZED ACTIVE-CONTROLLED TRIAL OF MYCOPHENOLATE MOFETIL IN HEART TRANSPLANT RECIPIENTS1 Hit paper breakdown → | 1998 | 498 |
| 8 | Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial Hit paper breakdown → | 2015 | 483 |
| 9 | Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension Hit paper breakdown → | 2013 | 469 |
| 10 | 2008 | 458 | |
| 11 | 2008 | 449 | |
| 12 | Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. | 1998 | 404 |
| 13 | 2006 | 397 | |
| 14 | 1995 | 360 | |
| 15 | 2014 | 346 | |
| 16 | 2002 | 311 | |
| 17 | 2007 | 311 | |
| 18 | 1997 | 267 | |
| 19 | 2005 | 215 | |
| 20 | Pulmonary vascular resistance and the risk of heart transplantation. | 1989 | 208 |
About Robert C. Bourge
Robert C. Bourge is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Pulmonary and Respiratory Medicine, Biomedical Engineering and Applied Psychology, having authored 252 papers that have together received 20.3k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (71 papers), Transplantation: Methods and Outcomes (67 papers), Pulmonary Hypertension Research and Treatments (38 papers), Mechanical Circulatory Support Devices (17 papers), Cardiac pacing and defibrillation studies (6 papers), Cardiac Valve Diseases and Treatments (4 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers) and Acute Kidney Injury Research (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (6.1k citations), Pulmonary and Respiratory Medicine (5.4k citations), Surgery (3.3k citations), Transplantation (132 citations) and Biomedical Engineering (952 citations). Robert C. Bourge has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include William T. Abraham, Lynne Warner Stevenson, Philip B. Adamson, James K. Kirklin, Maria Rosa Costanzo, David C. Naftel, Robyn J. Barst, Lewis J. Rubin, Mark F. Aaron and Stuart Rich. Their work appears in journals such as The Journal of Heart and Lung Transplantation, Journal of Cardiac Failure, Journal of the American College of Cardiology, Circulation and American Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.